Trade Medtronic MDT

Medtronic live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close change Change (%) Open High Low

Latest news

Tommy Yap 2025 Mar 22, 16:00

Week Ahead: Investor Eyes on U.S. Inflation & Core PCE for Fed’s Next Move

Forex Indices
Frances Wang 2025 Mar 20, 16:00

Stock indices news: US stock indices rose on Fed decision

Indices
Tommy Yap 2025 Mar 20, 16:00

Morning Note: Oil Sanctions, Canada Data, Ripple's Space Gamble

Morning Note Oil Forex
Frances Wang 2025 Mar 19, 16:00

US stock indices update: NASDAQ 100, Dow Jones 30 and S&P 500 Forecast

Indices
Tommy Yap 2025 Mar 19, 16:00

Morning Note: SNB Rate Cut Expected, BoE Decision & Accenture Earnings in Focus

Morning Note Forex
Frances Wang 2025 Mar 18, 16:00

Stock market today: NASDAQ Index, SP500, Dow Jones Forecasts

Stocks
Tommy Yap 2025 Mar 18, 16:00

Morning Note: BoJ Holds Rates, Fed Decision Looms & Tencent Earnings in Focus

Morning Note BoJ Fed
Frances Wang 2025 Mar 17, 16:00

Stock market today: Dow, S&P 500, Nasdaq remain steady on tariff tension

Stocks Indices

Info

Spread

0.55

Spread (%)

0.6102 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

116993613824

Shares Outstanding

1282540032

Earnings Date (Next)

1999-09-27

instr__dividend_date

2025-04-11

instr__ex_dividend_date

2025-03-28

instr__forward_annual_dividend_rate

2.8

instr__forward_annual_dividend_yield

0.0307

EPS

3.25

Learn more about this instrument

Medtronic Medtronic PLC
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments
Trustpilot